SynergEyes Hybrid (petrafocon A hem-larafilcon A) Hybrid Contact Lens
DeviceComparison to control hybrid lens with similar 'dose'minimum 8 hours daily use for up to 90 days.
NCT Number: NCT00804505
The purpose of the study is to demonstrate that the SynergEyes SA Hybrid Contact Lens clinical performance is substantially equivalent to that of the SynergEyes A Hybrid Lens when studied:
* within the corresponding range of lens powers * in a population randomized within multiple investigational sites * with a study ration of 2/1 test vs control lenses * for a duration of 90 days.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Carmel Mountain Vision Care, San Diego, California, United States
The objective of the study is to compare the SynergEyes SA Hybrid Contact Lens (Test) to the SynergEyes A Hybrid Contact lens (Control) when used in a daily wear regimen on non-diseased eyes for the correction of myopia (-0.25 to -6.00Diopters) with up to -2.50 Diopters of astigmatism. The population will be randomized into a 2/1 ratio of the Test/Control for 90 days. The study objective is to complete at least 40 subjects in the Test material and 20 subjects in the Control material.
The purpose of the study is to demonstrate that the SynergEyes SA Hybrid Contact Lens clinical performance is substantially equivalent to that of the SynergEyes A Hybrid Lens when studied within the corresponding range of powers in a population randomized within investigational sites to produce a 2/1 ratio of Test vs. Control lenses.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Prior to being considered eligible to participate in this study, each subject MUST:
Exclusion criteria
TO BE ELIGIBLE TO BE RANDOMIZED FOR STUDY PRODUCT TRIAL A SUBJECT MUST HAVE ALL OF THE INCLUSION CRITERIA AND NONE OF THE EXCLUSION CRITERIA PRESENT.
TO BE ELIGIBLE FOR LENS DISPENSING, THE SUBJECT'S STUDY DEVICE CONTACT LENS VISUAL ACUITY MUST BE EQUAL TO OR BETTER THAN 20/30 IN EACH EYE
Comparison to control hybrid lens with similar 'dose'minimum 8 hours daily use for up to 90 days.
Comparison to test lens: Daily use for minimum 8 hours up to 90 days.
Time frame: 3 months
Time frame: 3 mo.
SynergEyes, Inc.
Industry
A 90 Day Multi-Center, Randomized, Parallel Group Daily Wear Investigation of a New Hybrid Lens SynergEyes SA Manufactured With a Rigid Gas Permeable Center (Petrafocon A) and a Silicone Hydrogel Skirt (Larafilcon A) Compared to SynergEyes A (Paflufocon D Hem-iberfilcon A)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06101017
Corneal Disease, Corneal Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT02386774
Blepharitis, Corneal Disease
Saint-Etienne, Dermatology, France
View Trial DetailsNCT03990506
Corneal Biomechanics, Corneal Crosslinking
Umeå, Sweden
View Trial DetailsNCT04318132
Corneal Disease, Corneal Diseases
Andover, Massachusetts, United States
View Trial Details